Meeting global health challenges: Karolinska President discusses how Clinical Pharmacologists can help

The 14th EACPT Congress was held from 29th June to 2nd July in 2019 in Stockholm as a partnership between the EACPT and the Swedish Society for Pharmacology, Clinical Pharmacology and Therapeutics.

Keynote opening speaker at the EACPT Congress Professor Ole Petter Ottersen discusses how Clinical Pharmacologists in Europe and beyond can help to meet current global health challenges. In particular he notes that 14 of the 17 current WHO strategic development goals are relevant to safe, effective and equitable use of medicines. He also stresses the need to be aware of and address 'sticky institutions', whether governmental, NGO or commercial as barriers to improving global health policy and its implementation.

Professor Ottersen chaired the international Lancet Commission that studied the political determinants of global health inequalities (The Lancet-University of Oslo Commission on Global Governance for Health).

Discussants  
Professor Ole Petter Ottersen, President, Karolinska Institute

Professor Donald Singer: co-opted member of the Executive Committee of the EACPT.

The next EACPT Congress
The next EACPT biennial congress will be held in Athens. The programme will provide an international scientific and educational forum for discussion of clinical pharmacology and therapeutics, including personalised pharmacotherapy. See more on our website.

Joining the EACPT
Anyone from anywhere in the world with a professional interest in clinical pharmacology and therapeutics can now join the EACPT as an Individual Associate member.

Membership benefits include:

* Discounted registration fees for EACPT meetings
* Online subscription to the EACPT Official journal: the European Journal of Clinical Pharmacology
* Access to the EACPT’s worldwide network of Individual Associate Members
* Active involvement in EACPT 

25th Anniversary
The EACPT was founded 25 years ago and now includes as members all major national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth. Find out more about the EACPT ...

Future EACPT Congresses

2021  Athens

2023  Rotterdam

2025  Helsinki

Still time to submit an abstract for the EACPT Congress in Sweden: 29th June to 2nd July 2019

Stockholm

The next EACPT Congress will be held from 29th June to 2nd July in 2019 in Stockholm as a partnership between the EACPT and the Swedish Society for Pharmacology, Clinical Pharmacology and Therapeutics.

The Congress will address Tomorrow's Healthcare Challenges and will be held at the City Conference Centre - 5 minutes from Stockholm Central Station.

Abstract closing date extended to 14th March.

Register online

The Congress Reception on the evening of Saturday 29th June, will be held at Stockholm City Hall, the venue of the Nobel Prize banquet.

The Keynote Opening Lecture will be given by the President at the Karolinska Institute, Professor Ole Petter Ottersen, on global health and clinical pharmacology.

Around 60 invited speakers are expected from throughout Europe and beyond. Congress keynote lectures, sessions and themes will include:

• Advanced therapies
• Chronic disease
• Clinical pharmacologists versus computers
• Closing the money gap  
• Drug regulation in the 2020's
• EACPT meets Asian Societies      
• EPHAR-EACPT joint symposium on personalised medicine
• Ethics in clinical research
• Global Health
• How to become a clinical pharmacologist
• How to measure drug exposure
• How to measure drug use
• How to perform a health economic study
• Interprofessional exchange for better drug treatment
• Misuse of medicines
• Patient empowerment
• Preparing tomorrow's prescribers
• Prescribing and deprescribing
• Targeting small populations  
• The critically ill patient
• Treating ageing populations 
• Treating cancer
• Treating children

Major awards to be presented at the Stockholm Congress include the EACPT Lifetime Achievement Award and the biennial EACPT Scientific Award for best publication on a clinical pharmacology or therapeutic theme.

Opportunities for EACPT Associate Members include
* discounted registration fees for EACPT meetings
* networking with colleagues worldwide through the global EACPT network of Associate Members
* active involvement in EACPT Working Parties and other activities 

Find out how to become an Associate Member of the EACPT 

Future EACPT Congresses will be held in:
- 2021 Athens
- 2023 Rotterdam

The EACPT was founded in 1993 and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Pharmacology and therapeutics education in the EU needs harmonisation and modernisation

The EACPT has supported a European study of clinical pharmacology and therapeutics education which has now just been published in the journal Clinical Pharmacology & Therapeutics.

Effective teaching in pharmacology and clinical pharmacology and therapeutics (CPT) is necessary to make medical students competent prescribers. However, the current structure, delivery and assessment of CPT education in the European Union (EU) is unknown. 

In this study, the authors evaluated the current structure, delivery and assessment of clinical pharmacology and therapeutics education in the European Union. The authors conclude from a cross-sectional survey among 185 medical schools in 27 countries that pharmacology and therapeutics education in the EU needs harmonisation and modernisation. 

The manuscript is now freely accessible as an abstract and as a full paper through the journal.

The next EACPT Congress is to be held in Prague from 24-27 June 2017.

Register for the Prague Congress

Charles Bridge, Prague

-  22 sessions with Keynote Lectures on current issues for research, education and clinical practice on safe and effective use of medicines  

- almost 500 oral and poster presentations from the European Region and around the world  

- presentation of EACPT Lifetime Achievement (Professor Pertti J.Neuvonen, Finland) and Scientific Awards 

- opportunity to network with global experts and trainees in the fields of research, clinical practice, the biotechnology sector, regulation and health policy  

- update on the activities of the EACPT Working Groups for Research, Education, Regulation and Young Pharmacologists.

More on the Prague Congress

Click here to apply online for EACPT membership

Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member. 

There are reduced joining fees for Individual Associate members who are already members of a national or international organisation relevant to clinical pharmacology and therapeutics.

Register for updates on safety and effectiveness of medicines at EACPT Prague Congress - 24-27 June 2017

Rotterdam 7th April, 20017

The EACPT Executive Committee are meeting in Rotterdam to agree final details of the next EACPT Congress to be held in Prague from 24-27 June 2017.

Register for the Prague Congress

Early registration deadline 17 April

Standard registration deadline 16 June

Highlights of the Congress will include

-  22 sessions with Keynote Lectures on current issues for research, education and clinical practice on safe and effective use of medicines  

- almost 500 oral and poster presentations from the European Region and around the world  

- presentation of EACPT Lifetime Achievement (Professor Pertti J.Neuvonen, Finland) and Scientific Awards 

- opportunity to network with global experts and trainees in the fields of research, clinical practice, the biotechnology sector, regulation and health policy  

- update on the activities of the EACPT Working Groups for Research, Education, Regulation and Young Pharmacologists.

 

Charles Bridge - Prague

More on the Prague Congress

The programme will provide an international scientific and educational forum for discussion of clinical pharmacology and therapeutics, including personalised pharmacotherapy.

Themes will include the latest developments on effectiveness and safety of medicines, clinical pharmacology in clinical practice, pharmacokinetics/systems pharmacology, including in special populations, innovative techniques, eHealth, biomarkers, education, advanced practices in topics such as drug discovery, drug development, biological therapies, global health with a focus on access to safe medicines, new pharmacology and pharmacotherapy, safety in prescribing and updates on personalised medicines, as well as updates on specific therapeutic areas, including cardiovascular disease, infectious disease, nephrology, oncology, neurology and psychiatry.

Click here to apply online for EACPT membership. 

Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member. 

There are reduced joining fees for Individual Associate members who are already members of a national or international organisation relevant to clinical pharmacology and therapeutics.

Membership benefits include:

* Access to videos of talks from EACPT Meetings

* Discounted registration fees for EACPT meetings

* Online access to the Official EACPT Journal - Clinical Therapeutics

* Access to the EACPT’s worldwide network of Individual Associate Members

* Active involvement in EACPT

The 2019 EACPT Congress will be held in Stockholm and the 2021 EACPT Congress in Athens.

The EACPT was founded 25 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Clinical Therapeutics, the Official Journal of EACPT.

Submit abstracts for "How to Assess Medicines from Research to Clinical Practice": 6-9 October 2016. EACPT Focus Meeting - Opatija, Croatia.

The next EACPT Focus Meeting will be held from 6th to 9th October, 2016 in partnership with the Croatian Society for Clinical Pharmacology and Therapeutics.

The theme of the meeting is “How to Assess Medicines from Research to Clinical Practice”.

There will be a bursary fund of 10,000 € to support abstract presenters.

See meeting programme

Key dates

Abstract Submission Deadline - June 15, 2016

Early Registration Deadline - June 30, 2016

Online Meeting Registration Deadline - September 30, 2016  

 

The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner.

The meeting will include a combination of scientific podium lectures, interactive workshops and guided poster sessions covering three main pillars important for the critical assessment of medicinal products - efficacy, effectiveness, and economics (3E assessment).

There will be a dedicated session for Young Pharmacologists during the meeting. There will be an EACPT Scientific Communication Award for the best presentation by a young scientist. 

Confirmed speakers and topics

JANNE TAPIO BACKMAN (Finland): Clinical drug-drug interaction studies: methods, pitfalls and interpretation

NADA BOŽINA (Croatia): The role of pharmacogenetics in individulized treatment choices

YLVA BOTTIGER (Sweden): National model for the introduction and follow-up of new, expensive drugs in Sweden

GONZALO CALVO (Spain): Accelerated approval paths. What they do mean and what they should not mean?

SIMON MAXWELL (UK): Safe introduction of new medicines into clinical practice

KEN PATERSON (UK): Rapid Health Technology Assessment of New Medicines - Lessons from 15 Years Experience in Scotland

WORKSHOP 2: EXCELLENCE IN CLINICAL RESEARCH - CLINICAL TRIAL DESIGN

IGOR FRANCETIĆ (Croatia): Effectiveness assessment: when pharmacokinetics makes a difference / macrolide and azalide examples

MATTHIAS SCHWAB (Germany): Pharmacogenomics and drug response: future challenges

EDUARDO SPINA (Italy): Efficacy of antidepressants: issues related to bias in clinical trials

TABASSOME SIMON (France): Key points for building succesful clinical trial

SINIŠA TOMIĆ (Croatia): The Role of the National Competent Authority (NCA) in the Assessment of Medicinal Products in the National Procedure

DONALD SINGER (UK): Personalised medicine approaches for identifying effective therapies

SLOBODAN VUKIČEVIĆ (Croatia): Current challenges and hurdles in new drug development

We will be guests in the Adriatic coastal town Opatija, Croatia. Opatija lies at the centre of the Kvarner Riviera with the longest tradition of providing quality conference venues in Croatia. Opatija’s very attractive geographic location, lush green scenery and a pleasant climate (45° 20’ north latitude) were some of the main reasons for its origins and the rapid development of its tourism from the end of the 19th century.  The venue – Grand Hotel 4 Opatijska Cvijeta –  is located in the very centre of Opatija and includes four buildings that were named after Opatija’s best-known flowers. The hotel has 223 rooms. The hotel also includes the large Tamaris congress centre, which has 7 multi-functional halls and the latest congress equipment.

Anyone from anywhere in the world with a professional interest in clinical pharmacology
and therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:

• Access to videos of talks from EACPT Meetings

• Discounted registration fees for EACPT meetings

• Online access to the Official EACPT Journal - Clinical Therapeutics

• Access to the EACPT’s worldwide network of Individual Associate Members

• Active involvement in EACPT 

The EACPT was founded 24 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Update from Prague on the EACPT

The EACPT Executive Committee have met in Prague from 13th - 14th May to plan for

Charles Bridge - Prague

its future activities.

These include:

1. A joint EACPT session with EPHAR in Istanbul, June 26-30th 2016.
2. Our next Focus Meeting to be held in Opatija in Croatia from 6th - 9th October 2016
3. The exciting programme shaping up for the EACPT Prague Congress (24-27 June 2017)
4. Plans for major EACPT Awards due in 2017 (Lifetime Achievement - deadline 31st October, 2016; Scientific Award - deadline 31st January, 2017)
5. Support by the EACPT of the new UEMS Clinical Pharmacology Section
6. Activities of the EACPT Working Groups for Research, Education, Regulation and Young Pharmacologists.

October 6-9th 2016 EACPT Focus Meeting on how to assess medicines ...

The theme of the October 6-9th 2016 EACPT Focus Meeting is “How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment”. 

The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner. 

Abstract deadline: June 15th 2016
Early registration deadline: June 30th 2016

EACPT Prague Congress - 24-27 June 2017

The programme will provide an international scientific and educational forum for discussion of clinical pharmacology and therapeutics, including personalised pharmacotherapy.

Themes will include the latest developments on effectiveness and safety of medicines, clinical pharmacology in clinical practice, pharmacokinetics/systems pharmacology, including in special populations, innovative techniques, eHealth, biomarkers, education, advanced practices in topics such as drug discovery, drug development, biological therapies, global health with a focus on access to safe medicines, new pharmacology and pharmacotherapy, safety in prescribing and updates on personalised medicines, as well as updates on specific therapeutic areas, including cardiovascular disease, infectious disease, nephrology, oncology, neurology and psychiatry.

Members of the EACPT Executive Committee in Prague: Back Row: Matthias Schwab (Germany), Donald Singer (UK), Edoardo Spina (Italy), Tabassome Simon (France), Caroline Samer (Switzerland), Marie Besson (Switzerland), Milan Grundmann (Czech Republic); Front ROw: Simon Maxwell (UK), Dinko Vitezic (Croatia), Janne Backman (Finland), Ylva Böttiger (Sweden), Gerard Rongen (Netherlands).

The 2019 EACPT Congress will be held in Stockholm and the 2021 EACPT Congress in Athens. 

Click here to apply online for EACPT membership. 

Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member. 

There are reduced joining fees for Individual Associate members who are already members of a national or international organisation relevant to clinical pharmacology and therapeutics.

 

Membership benefits include:

• Access to videos of talks from EACPT Meetings
• Discounted registration fees for EACPT meetings
• Online access to the Official EACPT Journal - Clinical Therapeutics
• Access to the EACPT’s worldwide network of Individual Associate Members
• Active involvement in EACPT

The EACPT was founded 24 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Clinical Therapeutics, the Official Journal of EACPT.

New Year plans for the EACPT

We wish all our national society and individual members all the best for the festive season and for 2016.

The New Year will see further major activities for the EACPT. These include:

The next EACPT Focus Meeting will be held from 6th to 9th October, 2016 in partnership with the Croatian Society for Clinical Pharmacology and Therapeutics. The theme of the meeting is “How to Assess Medicines from Research to Clinical Practice".

The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner.

Planning is already well underway for the next biennial EACPT Congress, to be held in Prague from 23^rd – 27^th June in 2017. As part of Congress preparations, the next meeting of the EACPT Executive Committee will be in May in Prague.

Following the launch of a new individual associate membership for the EACPT, further working groups have been launched, complementing the established EACPT Education Working Group.These working groups provide excellent opportunities to become actively involved in the running of the EACPT.

EACPT Working Groups:

• Young Clinical Pharmacologists
• Education
• Ethics
• Regulatory 
• Research  

Click here to apply online for EACPT individual membership. 
 
Anyone from anywhere in the world with a professional interest in clinical pharmacology and therapeutics can now join the EACPT as an Individual Associate member. Membership benefits include:

• Active involvement in the EACPT  
• Access to videos of talks from EACPT Meetings 
• Discounted registration fees for EACPT meetings 
• Online access to the Official EACPT Journal - Clinical Therapeutics
•  Access to the EACPT’s worldwide network of Individual Associate Members

The EACPT was founded 23 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.